DISPOSABLE ENEMA- docusate sodium enema

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)

Available from:

Vedco Incorporated

Administration route:

RECTAL

Prescription type:

OTC

Therapeutic indications:

As an aid in the relief of constipation. For relief of impaction caused by hard fecal masses in dogs and cats.

Authorization status:

unapproved drug other

Summary of Product characteristics

DISPOSABLE ENEMA- DOCUSATE SODIUM ENEMA
VEDCO INCORPORATED
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
DISPOSABLE ENEMA FOR DOGS AND CATS
EACH SYRINGE CONTAINS:
250 mg. dioctyl sodium sulfosuccinate in glycerine U.S.P.
ACTION:
Lubricates and softens stool.
INDICATIONS:
As an aid in the relief of constipation.
For relief of impaction caused by hard fecal masses in dogs and cats.
ADMINISTRATION:
Gently insert flexible nozzle into rectum and press plunger to express
contents. In resistant cases,
treatment may be repeated in one hour.
WARNINGS:
KEEP OUT OF REACH OF CHILDREN
FOR VETERINARY USE ONLY
NET CONTENTS:
12 mL
PRINCIPAL DISPLAY PANEL:
NDC 50989-237-07
DISPOSABLE ENEMA
For Dogs and Cats
NET CONTENTS: 12 mL
VEDCO
Manufactured For:
VEDCO, INC.
St. Joseph, Missouri 64507
DISPOSABLE ENEMA
docusate sodium enema
PRODUCT INFORMATION
PRODUCT T YPE
OTC ANIMAL DRUG
ITE M CODE (SOURCE )
NDC:50 9 8 9 -237
ROUTE OF ADMINISTRATION
RECTAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
DO CUSATE SO DIUM (UNII: F0 5Q2T2JA0 ) (DOCUSATE - UNII:M7P2719 5AG)
DOCUSATE SODIUM
250 mg in 12 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SO RBIC ACID (UNII: X0 45WJ9 8 9 B)
GLYCERIN (UNII: PDC6 A3C0 OX)
Vedco Incorporated
PRODUCT CHARACTERISTICS
COLOR
blue
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:50 9 8 9 -237-0 7
12 mL in 1 SYRINGE
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 7/30 /19 9 6
LABELER -
Vedco Incorporated (021634266)
Revised: 11/2018